Follow on Google News Industry News News By Place Country(s) Industry News
Follow on Google News | Program for the 2009 Pacific Drug Safety Summit Announced, Registration OpensConference Host and Organizer BioSoteria announces that the Scientific Program has been released and registration is now open for the third annual Pacific Drug Safety Summit in San Francisco, September 25, 2009
By: BioSoteria Since its inception, the Pacific Drug Safety Summit has grown to be one of the largest and most successful West Coast drug safety and pharmacovigilance conferences and networking events. Drug safety professionals and service providers alike keep coming back to PDSS each year due to the quality of the presentations, the diversity of the speakers and topics, and the opportunity to network with more than 100 drug safety practitioner attendees and numerous vendors sponsoring the event. Scientific Program This year’s event offers eight contemporary topics presented by internationally known thought-leaders in drug safety and pharmacovigilance. Topics and invited speakers include the following: Morning Keynote: Quantitative Safety Signal Detection: CIOMS Working Group VIII Andrew Bate, PhD, MA Director, Quantitative Epidemiologist, Pfizer, Inc. Quantitative Risk Benefit Assessment Paul Coplan, Sc.D, MBA Senior Director, Risk Management, Global Safety Surveillance and Epidemiology, Wyeth Pharmaceuticals Religion and Politics: Controversial issues in Data Monitoring Committees David Kerr, MS, Project Director, Axio Research Use of Electronic Health Record Data in Pharmacovigilance Robert Dubois, MD, PhD Chief Medical Officer, Cerner Life Sciences Afternoon Keynote: International Drug Safety Landscape: Challenge and an Opportunity for Change Rebecca Wang MD, FRCP, FACC Head, Regional Center, Asia Pacific Pharma Development, Drug Safety Operation, Roche Online Capture of AEs from Call Centers and Import into Safety Systems Brian Dinardo Partner, Foresight Group Risk Management Plan (RMP) for Extraneal Robin Geller, PhD Director of Risk Management, Global Pharmacovigilance, Baxter Healthcare Corporation Post-marketing Studies and Registries Associated with REMS Cathy Sigler, DVM, PhD Sr. Director, Safety, Epidemiology, Registries, & Risk Management, United BioSource Corporation Attendees will have the opportunity throughout the event to participate in networking breaks and a panel discussion, as well as interact with a diverse assemblage of drug safety and pharmacovigilance attendees and sponsoring vendors. Breakfast and lunch will also be served and is included in the registration fee. Registration Due to the generous support of the conference sponsors, BioSoteria is able to again offer an affordable registration fee for conference attendees. The early bird registration fee to attend this full, one-day conference is $225 for those who register by Monday, August 31; the full registration fee is $295 for those who register after August 31. Questions about registration may be directed to PDSS Conference Planner Email or 1-866-660-5553. Online registration and more information are available at www.pacificdrugsafetysummit.com. Sponsorship Conference Sponsors to date include the following: • APCER Pharma Solutions • Aris Global • Axio Research • BioSoteria • Cerner Galt • Drug Logic • Foresight Group • November Research Group • Phase Forward • Sentrx • Synteract • United BioSource Corporation (UBC) Space remains for a few additional sponsors, although exhibit space is filling quickly. To learn more, contact the conference host BioSoteria at contact@biosoteria.com or 1-866-660-5553 x010 today to reserve your sponsorship at the one of the largest drug safety conferences and networking events held in the Western U.S. Venue and Lodging BioSoteria, Inc., the conference organizer, is pleased to host this year’s event at the new, state-of-the- About BioSoteria BioSoteria delivers high quality, innovative drug safety, pharmacovigilance, and therapeutic risk management consultant services and educational programs to the biopharmaceutical and healthcare community. For more information about BioSoteria and our services and educational programs, please email contact@biosoteria.com, visit our website at www.biosoteria.com, or call +1 866-660-5553. Contact Michelle Flewell VP, eLearning & Informatics BioSoteria, Inc. 6425 Christie Avenue, Suite 220 Emeryville, CA 94608 pacificdrugsafetysummit@ 1-866-660-5553 x013 Website: Conference: www.pacificdrugsafetysummit.com Host/Organizer: # # # About BioSoteria BioSoteria delivers high quality, innovative drug safety, pharmacovigilance, and therapeutic risk management consultant services and educational programs to the biopharmaceutical and healthcare community. For more information about BioSoteria and our services and educational programs, please email contact@biosoteria.com, visit our website at www.biosoteria.com, or call +1 866-660-5553 End
|
| ||||||||||||||||||||||||||||||||||||||||||
